Keyphrases
Tumor Microenvironment
93%
Immune Modulatory Vaccine
80%
Specific T Cells
62%
Anticancer Immunity
53%
Transforming Growth Factor-β
53%
Peptide Vaccine
35%
Pancreatic Cancer
32%
Cancer-associated Fibroblasts
31%
Regulatory T Cells
31%
Derived Peptide
30%
Murine Model
30%
Peptide Vaccination
29%
Tumor-associated Macrophages
28%
Anti-PD-1
26%
Arginase-1 (Arg-1)
26%
PD-1 Blockade
26%
Synergize
26%
Vaccine Target
26%
Arginase 2
26%
Galectin-3 (Gal-3)
26%
CCL22
26%
Cytotoxic T Cells
26%
Pancreatic Ductal Adenocarcinoma
16%
Tumor
15%
Vaccination
14%
Immunosuppression
14%
M2 Macrophages
12%
Tumor Growth
11%
Pan02
10%
CD8+ T Cells
8%
ELISPOT
8%
Fibroblasts
8%
Immune Regulation
8%
Flow Cytometry
8%
Syngeneic Mouse Model
7%
MHC Class II
7%
Quantitative PCR
7%
Cancer Patients
6%
Myofibroblast
6%
Treg
6%
T Cells
6%
Immune Infiltration
5%
Immune-related Genes
5%
Fibrosis
5%
Gene Expression
5%
Healthy Donors
5%
Immunotherapeutic Approaches
5%
Immune Response
5%
Myeloid Cells
5%
Infiltration
5%
Immunology and Microbiology
T Cell
100%
Vaccine Efficacy
85%
Immunosuppressive Drug
55%
Vaccination Policy
55%
Tumor Immunity
53%
Transforming Growth Factor
53%
Peptide Vaccine
41%
Mouse
40%
Tumor-Associated Macrophage
37%
Regulatory T Cell
37%
Fibroblast
29%
Cytotoxic T-Cell
27%
CCL22
26%
Galectin 3
26%
Cytotoxic T Cell
26%
Syngenic
20%
Myeloid
19%
Immune Response
18%
Cancer Associated Fibroblast
16%
Immunotherapy
16%
Epitope
15%
Immunosuppression
14%
ELISPOT
13%
Interferon Gamma
13%
M2 Macrophages
12%
Quantitative Reverse Transcription Polymerase Chain Reaction
11%
Cancer Cell
10%
Cell Infiltration
10%
Major Histocompatibility Complex
10%
Antigen Specificity
8%
Enzyme-Linked Immunospot Assay
8%
Normal Human
8%
Immunosurveillance
8%
Cell Composition
8%
Adoptive Immunity
8%
Myofibroblast
6%
Immunocompetent Cell
6%
Immune Cell Infiltration
5%
Gene Expression
5%
C57BL 6 Mouse
5%
